Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates
NCT00986947
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Kidney Failure
Interventions
DRUG:
IVIg and rituximab
Sponsor
Johns Hopkins University